Current status of radiotherapy with proton and light ion beams (Q34576474)

3 August 2017

1 reference

title

Current status of radiotherapy with proton and light ion beams (English)

1 reference

adaptive radiation therapy

3 August 2017

main subject

0 references

author name string

Carlo Greco

series ordinal

1 reference

3 August 2017

Suzanne Wolden

series ordinal

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

109

1 reference

3 August 2017

1 reference

3 August 2017

page(s)

1227-1238

1 reference

The clinical potential of intensity modulated proton therapy

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

Evidence-Based Estimates of Outcome in Patients Irradiated for Intraocular Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

The relative costs of proton and X-ray radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

The centenary of the discovery of the Bragg peak

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Treatment planning and verification of proton therapy using spot scanning: initial experiences

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Number of patients potentially eligible for proton therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

The case for particle therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Interpretation of proton relative biological effectiveness using lesion induction, lesion repair, and cellular dose distribution

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Examination of GyE system for HIMAC carbon therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Orbital development in long-term survivors of retinoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Quantification of orbital and mid-facial growth retardation after megavoltage external beam irradiation in children with retinoblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Proton radiation therapy for retinoblastoma: comparison of various intraocular tumor locations and beam arrangements

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Radiotherapy for local control of osteosarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Uveal melanoma: proton beam irradiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Ten-year follow-up of helium ion therapy for uveal melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Proton teletherapy of uveal melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Eye retention after proton beam radiotherapy for uveal melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Proton radiation therapy for chordomas and chondrosarcomas of the skull base

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Proton therapy for tumors of the skull base

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Proton radiotherapy in management of pediatric base of skull tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Results of carbon ion radiotherapy in 152 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Treatment planning intercomparison for spinal chordomas using intensity-modulated photon radiation therapy (IMRT) and carbon ions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Radiation therapy alone in early stage non‐small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Proton-beam radiotherapy for early-stage lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

High-dose proton beam therapy for Stage I non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Clinical evaluation of proton radiotherapy for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Preoperative carbon ion radiotherapy for non-small cell lung cancer with chest wall invasion—pathological findings concerning tumor response and radiation induced lung injury in the resected organs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Carbon ion radiotherapy for stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Risk of cardiac death after adjuvant radiotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Cardiac morbidity of adjuvant radiotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Late Cardiac Mortality and Morbidity in Early-Stage Breast Cancer Patients After Breast-Conservation Treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

The relationship of radiation pneumonitis to treated lung volume in breast conservation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Node-positive left-sided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Accelerated partial breast irradiation using proton beams: Initial dosimetric experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Dose response in prostate cancer with 8-12 years' follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Radiation-induced second cancers: the impact of 3D-CRT and IMRT

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Protons or megavoltage X-rays as boost therapy for patients irradiated for localized prostatic carcinoma an early phase I/II comparison

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Proton therapy for prostate cancer: the initial Loma Linda University experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Fast neutron radiotherapy for locally advanced prostate cancer. Final report of Radiation Therapy Oncology Group randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer: results of a randomized prospective trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Neon ion radiotherapy: results of the phase I/II clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Phase I/II clinical trials of carbon ion therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Hypofractionated radiotherapy with carbon ion beams for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Carbon ion radiation therapy for prostate cancer: results of a prospective phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Evaluation of therapeutic potential of heavy ion therapy for patients with locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Relative biological effectiveness of neutrons for cancer induction and other late effects: a review of radiobiological data.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Intensity-modulated radiation therapy, protons, and the risk of second cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Secondary neutron dose during proton therapy using spot scanning

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Second neoplasms following megavoltage radiation for pediatric tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Bone sarcomas linked to radiotherapy and chemotherapy in children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Radiation-induced osteosarcomas in the pediatric population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Is there an increased risk of second primaries following prostate irradiation?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Proton therapy of cancer: potential clinical advantages and cost-effectiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Protons to replace photons in external beam radiation therapy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

The potential of proton and light ion beams in radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Protons. A step forward or perhaps only more expensive radiation therapy?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.22542

1 reference

7 January 2021

Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Economic evaluation of proton radiation therapy in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

The potential of proton beam radiation therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22542

7 January 2021

Identifiers

DOI

10.1002/CNCR.22542

1 reference

3 August 2017

1 reference